Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study

Federico Cavanna,1,2 Stephanie Muller,1 Laura Alethia de la Fuente,1,3 Federico Zamberlan,1,4 Matías Palmucci,1 Lucie Janeckova,5 Martin Kuchar,5,6 Carla Pallavicini,#1,2 and Enzo Tagliazucchi#1,7

Check out this article published in August 2022, in the National Library of Medicine

Abstract:

The use of low sub-perceptual doses of psychedelics (“microdosing”) has gained popularity in recent years. Although anecdotal reports claim multiple benefits associated with this practice, the lack of placebo-controlled studies severely limits our knowledge of microdosing and its effects. Moreover, research conducted in standard laboratory settings could fail to capture the motivation of individuals engaged or planning to engage in microdosing protocols, thus underestimating the likelihood of positive effects on creativity and cognitive function…

Click here to read the rest of the article.